The addition of salmeterol 50 microg bid to anticholinergic treatment in patients with COPD: a randomized, placebo controlled trial. Chronic obstructive pulmonary disease.

Kenneth R. Chapman,Peter Arvidsson,Ag Chuchalin,Dp Dhillon,Peter Faurschou,Roger S. Goldstein,Af Kuipers

The addition of salmeterol 50 microg bid to anticholinergic treatment in patients with COPD: a randomized, placebo controlled trial. Chronic obstructive pulmonary disease.

2002

Kenneth R. Chapman
Peter Arvidsson
Ag Chuchalin
Dp Dhillon
Peter Faurschou
Roger S. Goldstein
Af Kuipers

BACKGROUND: In the past, the role of long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD) relative to other agents has been unclear.

Keywords:

Physical therapy
Salmeterol
Disease
Placebo-controlled study
Anesthesia
Anticholinergic
COPD
Medicine
in patient
pulmonary disease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations